Using Artificial Intelligence to Identify TRAF2- and NCK-Interacting Kinase as a Target for Fibrosis

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Synfacts 2024; 20(07): 0751
DOI: 10.1055/s-0043-1774881

Innovative Drug Discovery and Development

Contributor(s):

Antonia F. Stepan (Roche)

,

Nicholas A. Meanwell (Baruch S. Blumberg Institute, U. Michigan, Rutgers. U.)

Key words

artificial intelligence - TRAF2- and NCK-interacting kinase inhibitor - anti-fibrotic activity

Article published online:
14 June 2024

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany